Herborium to Hold Shareholder Conference Call
November 02 2010 - 8:37AM
Herborium Group, Inc., (Pink Sheets:HBRM) www.herborium.com, a
Botanical Therapeutics™ company, today announced Dr. Agnes
Olszewski, Herborium Group's president and chief executive officer,
will hold a shareholder conference call on Wednesday, November 3,
2010, at 4:15 PM EDT, to discuss its 2011 marketing plan and make
an important announcement to shareholders.
Shareholders can participate on Wednesday, November 3, 2010, by
dialing (805) 309-0111 and entering access code 646614, up to 10
minutes before the call, beginning at 4:15 PM EDT, 3:15 PM CDT,
2:15 PM MDT, and 1:15 PM PDT.
"I look forward to speaking with Herborium's shareholders during
this upcoming call," commented Dr. Agnes P. Olszewski, Herborium
Group's president and chief executive officer. "We will discuss our
new 2011 marketing plan, current product initiatives, and the
significant market opportunity afforded AcnEase® by the withdrawal
of Roche's Accutane®. I respectfully suggest that due to the dense
subject matter, those who wish should be prepared to take
notes."
Shareholder questions will also be answered during the call;
shareholders are encouraged to e-mail all questions for management
to herborium@smallcapss.com, any time before the call to ensure
questions are covered in the time allowed.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanically based medicinal products to consumers and healthcare
professionals. The Company's business model focuses on emerging
market opportunities spearheaded by the growth of a new market
sector located between high-cost, high-risk, ethical
pharmaceuticals and commoditized classic nutraceuticals
(supplements). The Company uses clinical validation and a
proactive regulatory strategy based on the FDA Guidance for
Industry: Botanical Drug Products (FDA Guidance 2004) to establish
and maintain a differential advantage. For more information, please
visit www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are
based on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or
"intends." We cannot promise future returns. Our
statements reflect our best judgment at the time they are issued,
and we disclaim any obligation to update or alter forward-looking
statements as the result of new information or future
events. The Company urges investors to review the risks and
uncertainties contained within its filings with the OTC Markets
and/or Securities and Exchange Commission.
CONTACT: Herborium Group, Inc.
Investor Relations
Steve Haag
(832) 413-6206
Herborium (PK) (USOTC:HBRM)
Historical Stock Chart
From May 2024 to Jun 2024
Herborium (PK) (USOTC:HBRM)
Historical Stock Chart
From Jun 2023 to Jun 2024